Last edited: October 30, 2026
When it comes to viruses and frequency therapy, the diagnosis and treatment goal must align. I, Herbert Eder, therefore distinguish between reliable pathogen detection, the relief of symptoms, and the elimination of an infection. The following article explains these detection steps using specific medical examples, without applying them to any other device.
The British Advertising Standards Authority (ASA) requires robust clinical evidence to support claims that bioresonance devices can reliably diagnose or treat diseases. Its current guidance states that it has no such evidence for the advertised diagnostic and therapeutic applications. Therefore, a frequency specification alone does not prove that a device effectively treats a viral infection in humans. [1]
When searching for information on viruses and frequency therapy, you’ll often find a wide variety of offerings side by side: treatments for symptoms, purported pathogen measurements, and promises of a complete cure. It’s helpful to start by asking a specific question: Which device is intended to achieve which verifiable result for which confirmed infection? Only then can the reasoning provided be meaningfully evaluated.
Why „against viruses“ is not a sufficiently precise statement
Viruses contain genetic material made of DNA or RNA, which is protected by a protein shell. They use living cells to reproduce. In the process, they can damage or alter cells; however, an infection does not always cause noticeable symptoms. The specific disease that develops and its course depend largely on the virus in question and the individual affected. [2]
The modes of transmission also differ. Depending on the virus, transmission can occur through the air, contaminated food or water, sexual contact, or contact with certain insects or animals. Therefore, a blanket concept of a single, universal „virus treatment“ is medically insufficient. A treatment must demonstrate its effectiveness for the specific infection it is claimed to treat, rather than merely listing the names of various pathogens. [2]
A reliable diagnosis requires appropriate tests
An electron microscope is not absolutely necessary to detect a viral infection. Suitable samples are often examined using molecular methods. PCR tests can detect small amounts of viral genetic material; depending on the clinical question, other tests may also be appropriate. A test result must be consistent with the type of sample, the timing of the test, and the patient’s symptoms. Even a highly sensitive test can detect remnants of genetic material after an active infection has already subsided. [3]
For certain respiratory illnesses, a laboratory panel can test for multiple viruses and bacteria at the same time. Such tests are particularly useful in cases of severe illness or an increased risk of complications, when the results can influence treatment. Not every panel detects the same pathogens, and not every cold requires a comprehensive test. The goal is to make an informed medical decision, not to compile the longest possible list of positive results. [4]
A report from a frequency-measuring device does not answer these questions simply by displaying percentages, colored bars, or known virus names. Ask about the sample material tested, the validated measurement method, the error rate, and the comparison with a recognized laboratory test. If this information is missing, it remains unclear what the displayed number actually measures and what conclusions should be drawn from it.
What Results Treatment Can Achieve
In the case of an uncomplicated cold, the primary focus is usually on relieving symptoms. Rest, staying well-hydrated, and, if necessary, taking appropriate remedies for bothersome symptoms can be part of the care plan. Antibiotics are not effective against the viruses that cause these illnesses. The Austrian health portal distinguishes between such measures and the treatment of additional bacterial complications; therefore, antibiotics are not automatically prescribed for every viral infection. [5]
For influenza, antiviral medications may be beneficial for certain individuals. They are most effective when treatment begins early; however, in cases of severe illness or increased risk, treatment may also be indicated at a later stage. The CDC emphasizes the importance of prompt evaluation, particularly in cases of pregnancy or relevant pre-existing conditions. Trying an alternative device first should not cause this treatment window to pass. [6]
Hepatitis C illustrates why the statement „Viruses can only be suppressed“ is also too sweeping. Modern direct-acting antiviral drugs can cure this infection in the vast majority of patients treated. A confirmed infection should therefore be treated by a doctor. The choice of therapy and the monitoring of its success are based on specific test results, not on a general promise of improved health. [7]
What concrete evidence of effectiveness looks like
In the ASTRAL-1 clinical trial, Feld and colleagues investigated a combination of two antiviral agents for specific hepatitis C genotypes. Of the 624 people treated, 99 percent achieved a sustained virologic response 12 weeks after the end of therapy. In the placebo group of 116 people, no one reached this endpoint. The evaluation was therefore not based solely on the fact that those receiving treatment subjectively felt better. Crucial factors were a precisely described drug, a clearly defined participant population, and a specified laboratory endpoint. The result applies to the treatment studied and cannot be generalized to other treatments. [8]
The NIH explains that clinical trials evaluate the benefits and risks of new treatments. Random assignment can reduce systematic differences between comparison groups; proper blinding limits the influence of expectations. In the case of serious illnesses, a comparison must not simply omit effective, necessary treatment. Such rules also apply when a procedure does not involve medication or is marketed as particularly natural. [9]
When reviewing a study, therefore, make sure it aligns with the product being promoted. Was the same device used? Were the participants actually infected with the virus mentioned? Did the study focus on symptoms, laboratory values, or complications? A study on pain relief cannot support the claim that a device eliminates hepatitis viruses. A headline does not replace this scrutiny.
Why a testimonial alone isn't enough
Suppose someone starts using a device and feels better a few days later. That is an important personal observation. However, it remains unclear how things would have progressed without the device and what other measures were taken at the same time. Therefore, to conclude that „the device was effective,“ a comparison is needed. The same question naturally applies to a pill, a dietary supplement, or an extensive clinical treatment as well.
The ASA has also pointed out, in the context of bioresonance advertising, that a CE marking alone does not provide evidence of the claimed efficacy. In cases it reviewed, the studies submitted did not correspond to the advertised diseases or did not allow for a reliable conclusion. The decisive factor, therefore, remains whether the specific diagnostic or therapeutic claim is supported by appropriate data. [1]
Electrical pain treatment is a distinct field of application
TENS, or transcutaneous electrical nerve stimulation using skin electrodes, is used to treat certain types of pain. The Royal National Orthopedic Hospital describes it as part of an individualized pain management plan. It does not automatically replace other necessary medications. A pain-relieving application does not provide evidence that viruses have been eliminated from the blood or organs. The treatment goal and assessment of success remain distinct. [10]
Even electrical devices are not inherently risk-free. The hospital lists, among other things, skin irritation and burns resulting from improper use, as well as situations that require prior professional evaluation. Read the specific product information and discuss any medical considerations. In particular, any implanted electronic devices should be discussed during this consultation; general advertising claims are no substitute for an individual safety assessment. [10]
What Laboratory Test Results and Technical Disinfection Cannot Prove
An in vitro study initially answers a question under its specific experimental conditions. It does not automatically follow that a procedure will reach all of a person’s infected cells, remain well-tolerated, and improve the course of the disease. Anyone promoting a treatment based on technical findings must provide this additional evidence. The terms „frequency,“ „resonance,“ and „energy“ do not bridge this gap in evidence.
A 2020 statement from the U.S. Federal Trade Commission (FTC) demonstrates that health-related advertising can cross precisely this line. Among other things, the FTC took issue with unsubstantiated claims that a product advertised as using Rife frequencies could cure COVID-19. This regulatory assessment is not a physics experiment; it documents that sound evidence is required to support the medical claims being marketed. [11]
When Waiting Can Be Dangerous
Severe shortness of breath or sudden chest pain requires immediate medical attention. If you have flu-like symptoms, pregnant women, older adults, and people with weakened immune systems, among others, should seek medical advice early on. The NHS also recommends seeking prompt medical evaluation if your condition worsens significantly. In such situations, do not wait for a supposed “cleansing effect” or for a treatment program to finish. [12]
The FDA warns that unproven health products can lead to delayed diagnosis and treatment. This also applies to products whose immediate use may initially seem harmless. Failure to consult a doctor, interruption of necessary therapy, or overlooking a warning sign can itself become a problem. Therefore, the use of complementary products should neither undermine confirmed medical findings nor unilaterally replace the agreed-upon treatment plan. [13]
Questions to Ask Before Making a Decision
Ask for the exact medical claim in writing and request the corresponding published study. Ask about the study population, the results of the control group, side effects, and any potential conflicts of interest. Also, clarify what criteria will be used to determine success or discontinuation. An answer that relies solely on personal conviction or refers to a large number of pre-set programs leaves these questions unanswered.
For a consultation at the doctor’s office, four pieces of information are often sufficient: the confirmed diagnosis, the current course of the condition, the treatment received so far, and the specific additional treatment being considered. This ensures that the decision is based on your actual problem. You do not need to refute every technical claim yourself or accept a promise of a cure on trust. Ask for verifiable evidence of the exact benefits being offered to you.
My take: A virus name is not a measurement method in and of itself
When providing medical advice, it is crucial to determine whether a result describes a sample that was actually tested or merely indicates a database entry. PCR and pathogen panels have defined testing purposes; nevertheless, their results must be interpreted within a clinical context. [3,4] A list of virus names in a software program cannot replace these requirements.
Similarly, a response to treatment must be distinguished from virological treatment success. The hepatitis C study described in the article measures a defined laboratory endpoint of a specific drug treatment. [8] Anyone who wishes to use this as general evidence in favor of frequency therapy would have to provide evidence for their own method.
This explains how the comparison group and the target variable are related Review studies on frequency therapy based on well-defined research questions.
The following explains why the inclusion of a pathogen on a list does not constitute evidence of treatment: Classifying CAFL Frequency Lists Correctly with regard to origin and the limits of what can be stated.
Sources and Further Information
- ASA/CAP: Bioresonance Therapy, Requirements for Clinical Evidence. Retrieved October 29, 2026.
- MedlinePlus: Viral Infections. Retrieved October 29, 2026.
- MedlinePlus: PCR Tests. Retrieved October 29, 2026.
- MedlinePlus: Respiratory Pathogens Panel. Retrieved October 29, 2026.
- Gesundheit.gv.at: Colds, Diagnosis, and Treatment. Retrieved October 29, 2026.
- CDC: Treating the Flu with Antiviral Drugs. Retrieved October 29, 2026.
- CDC: Treatment of Hepatitis C. Retrieved October 29, 2026.
- Feld et al. 2015: Sofosbuvir and Velpatasvir for HCV Genotypes 1, 2, 4, 5, and 6 Infection. Retrieved October 29, 2026.
- NIH: Clinical Research Trials and You: The Basics. Retrieved October 29, 2026.
- Royal National Orthopaedic Hospital: Patient Guide to TENS. Retrieved October 29, 2026.
- FTC, April 2020: Warning letters regarding unsubstantiated COVID-19 claims. Retrieved October 29, 2026.
- NHS: Flu, Symptoms, and Warning Signs. Retrieved October 29, 2026.
- FDA: Health Fraud Schemes. Retrieved October 29, 2026.
Topic Overview: Research and Studies.
Comments are closed, but trackbacks and pingbacks are open.